Page last updated: 2024-09-04

canertinib and Neoplasm Metastasis

canertinib has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arun, BK; Franco, SX; Johnston, SR; Letrent, SP; Martin, M; Rixe, O; Rugo, HS; Yardley, DA	1

Trials

1 trial(s) available for canertinib and Neoplasm Metastasis

Article	Year
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:6 Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; ErbB Receptors; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Morpholines; Neoplasm Metastasis; Receptor, ErbB-2; Receptor, ErbB-3; Receptor, ErbB-4; Receptors, Estrogen; Treatment Outcome	2009

Article

Year

A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer.

Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:6

Topics: Adult; Aged; Breast Neoplasms; Disease-Free Survival; ErbB Receptors; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Morpholines; Neoplasm Metastasis; Receptor, ErbB-2; Receptor, ErbB-3; Receptor, ErbB-4; Receptors, Estrogen; Treatment Outcome

2009